INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
119.000 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
119.000 |
Evidence |
|
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
119.000 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
119.000 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
119.000 |
Evidence |
|
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
119.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
119.000 |
Evidence |
|
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
119.000 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
STAT3 |
|
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
JAK1 |
|
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
119.000 |
Evidence |
|
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
119.000 |
Evidence |
|
WASPIP |
IPI00552369 |
CRK |
IPI00399054 |
118.000 |
Evidence |
|
DIAPH1 |
Diaphanous 1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
118.000 |
Evidence |
|
FGA |
IPI00021885 |
F13B |
F13B: Coagulation factor XIII B chain precursor |
118.000 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
118.000 |
Evidence |
|